Uncategorized 30 May 2025 BioNet and Bio Farma Sign Strategic MoU to Expand TdaP Vaccine Access in ASEAN BioNet
Uncategorized 30 Apr 2025 European Immunization Week 2025: Humanly possible Under the theme “Immunization for all is Humanly Possible”, this year’s campaign highlights the urgent need to achieve high and… Pantitra Laohatranon
Uncategorized 18 Apr 2025 How to improve pertussis vaccination in pregnancy: a European expert review How to improve pertussis vaccination in pregnancy: a European expert review Pertussis (whooping cough) remains a serious threat to infants,… BioNet
Uncategorized 11 Apr 2025 New Research Boosts Future Whooping Cough Vaccines Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the… Pantitra Laohatranon
Uncategorized 29 Mar 2025 Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses Skin patch delivery of a SARS-CoV-2 spike DNA vaccine produces broad neutralising antibody responses Since the emergence of severe acute… BioNet
Uncategorized 28 Mar 2025 Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined… BioNet
Uncategorized 25 Feb 2025 Thailand Leads the Way with World’s First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand Leads the Way with World's First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand's National Health Security Office (NHSO)… BioNet
Uncategorized 17 Jan 2025 BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation Lyon, France & Bangkok, Thailand – January 17, 2025 – BioNet, a global leader in vaccine innovation, proudly announces its… BioNet
Uncategorized 13 Jan 2025 LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition LTS and BioNet Win U.S. BARDA Patch Forward Prize Competition Andernach – LTS, a leading pharmaceutical technology company, and BioNet,… BioNet
Uncategorized 21 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known… BioNet
